Channing Capital Management LLC boosted its holdings in shares of Teradyne, Inc. (NASDAQ:TER – Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 89,737 shares of the company’s stock after buying an additional 8,291 shares during the quarter. Channing Capital Management LLC owned 0.06% of Teradyne worth $11,300,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TER. Daiwa Securities Group Inc. grew its position in shares of Teradyne by 11.0% during the fourth quarter. Daiwa Securities Group Inc. now owns 24,170 shares of the company’s stock worth $3,043,000 after buying an additional 2,390 shares in the last quarter. TradeLink Capital LLC acquired a new position in Teradyne during the 4th quarter worth approximately $460,000. AlphaQuest LLC increased its position in shares of Teradyne by 57.1% in the 4th quarter. AlphaQuest LLC now owns 3,694 shares of the company’s stock valued at $465,000 after purchasing an additional 1,343 shares during the last quarter. Roberts Glore & Co. Inc. IL raised its holdings in shares of Teradyne by 2.2% in the 4th quarter. Roberts Glore & Co. Inc. IL now owns 4,103 shares of the company’s stock valued at $517,000 after purchasing an additional 90 shares in the last quarter. Finally, Argentarii LLC acquired a new stake in shares of Teradyne in the 4th quarter valued at $487,000. Hedge funds and other institutional investors own 99.77% of the company’s stock.
Insider Activity
In other news, CEO Gregory Stephen Smith sold 3,080 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $130.00, for a total value of $400,400.00. Following the completion of the sale, the chief executive officer now directly owns 74,660 shares of the company’s stock, valued at $9,705,800. This trade represents a 3.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Richard John Burns sold 407 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $120.51, for a total value of $49,047.57. Following the transaction, the insider now directly owns 20,764 shares in the company, valued at $2,502,269.64. This represents a 1.92 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,479 shares of company stock valued at $1,013,134 over the last quarter. Corporate insiders own 0.36% of the company’s stock.
Teradyne Stock Down 3.3 %
Teradyne (NASDAQ:TER – Get Free Report) last released its earnings results on Wednesday, January 29th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Teradyne had a return on equity of 19.08% and a net margin of 19.23%. As a group, analysts anticipate that Teradyne, Inc. will post 3.88 earnings per share for the current year.
Teradyne declared that its Board of Directors has authorized a stock repurchase program on Monday, November 11th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 0.6% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.
Teradyne Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 14th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.46%. The ex-dividend date of this dividend is Friday, February 14th. Teradyne’s dividend payout ratio (DPR) is presently 14.41%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the company. KeyCorp dropped their target price on Teradyne from $180.00 to $150.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Morgan Stanley downgraded Teradyne from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $121.00 to $117.00 in a report on Tuesday, January 21st. Cantor Fitzgerald restated an “overweight” rating and set a $160.00 target price on shares of Teradyne in a research note on Thursday, January 30th. Susquehanna upped their price target on Teradyne from $145.00 to $165.00 and gave the company a “positive” rating in a report on Wednesday, January 22nd. Finally, Northland Securities cut their price objective on shares of Teradyne from $154.00 to $140.00 and set an “outperform” rating on the stock in a report on Friday, January 31st. One analyst has rated the stock with a sell rating, three have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $143.14.
Check Out Our Latest Research Report on TER
Teradyne Profile
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Read More
- Five stocks we like better than Teradyne
- Top Biotech Stocks: Exploring Innovation Opportunities
- How to Protect Your Portfolio When Inflation Is Rising
- The 3 Best Retail Stocks to Shop for in August
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.